• Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

  • Jul 19 2022
  • Length: 10 mins
  • Podcast

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Listen for free

View show details

  • Summary

  • Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.

    Read the full article:
    Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show More Show Less
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show More Show Less
activate_samplebutton_t1

What listeners say about Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.